Shanghai Junshi Bio's 2025 A-share stock option incentive plan equity allocation announced.

As of the authorization date, Shanghai Junshi BioPharmaceutical Technology Co., Ltd. announced the distribution of equity for the 2025 A-share stock option incentive plan. The incentive plan plans to distribute a total of 25.965871 million shares of equity, with an initial grant of 25.15 million shares, accounting for 96.86%. Chairman Xiong Jun was granted 8 million shares, accounting for 30.81% of the total number of stock options granted; the remaining 234 incentive recipients were granted 17.15 million shares, accounting for 66.05%. The remaining reserved portion is 0.815871 million shares, accounting for 3.14%. The plan complies with relevant regulations and excludes independent directors, supervisors, and senior executives as incentive recipients. The incentive recipients for the reserved portion will be determined and disclosed within 12 months.